To access AIS Channel content, please allow all cookies. Please click here to configure your preferences.
Rezūm Treatment for Benign Prostatic Hyperplasia (BPH)
Boston Scientific
Share
share
2020
Chat
keyboard_arrow_down
Description
keyboard_arrow_down
Management of symptomatic BPH is evolving and now includes several minimally invasive therapies which aim to improve urinary symptoms whilst maintaining a low likelihood of side-effects. Resection, vaporization and enucleation of prostate tissue allow for maximum tissue removal with excellent symptomatic benefits, but with a not insignificant risk of sexual dysfunction and incontinence. Furthermore, the side-effects of BPH medication may have been underestimated and some men would prefer to avoid taking medication. Rezūm is a novel interstitial therapy for BPH which uses convective heating to ablate prostate tissue. The 3-year results from a prospective randomized US trial have demonstrated encouraging and durable results with preservation of sexual function. It is quick and can be performed under local anesthetic. Rezūm uses the natural energy stored in water vapor, or steam. It is a safe and effective treatment available to relieve symptoms associated with benign prostatic hyperplasia, or BPH.
Case study details:
Patient 1 MW
51-year-old patient
Increasing problems with waterworks over last 18 months. Good response from using alpha blockers and finasteride
Flow tests and scans demonstrate residual of over 200mls and a very poor flow
Max flow rate at consultation was 5ml/second
Flexible cystoscopy confirmed obstructing trilobar prostate gland. Felt of modest size ad benign on DRE
Previous PSA of 0.5ug/L
Waiting list for HoLEP but heard about Rezūm and favourable side effect profile
